Cisplatin Is a DNA-Damaging Antitumour Compound Triggering Multifactorial Biochemical Responses in Cancer Cells: Importance of Apoptotic Pathways
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
251-265
Author(s):
Yuliya Sedletska, Marie-Josephe Giraud-Panis and Jean-Marc Malinge
Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
267-279
Author(s):
Nial J. Wheate and J. Grant Collins
Progress in the Development of Aminopeptidase N (APN/CD13) Inhibitors
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
281-301
Author(s):
Wenfang Xu and Qianbin Li
Anti-Cancer / Anti-Tumor
Journal:
Current Bioactive Compounds
Volume:
1
Page:
1-24
Author(s):
Bentham Science Publishers
Non-Viral Gene Delivery to the Lungs
Journal:
Current Gene Therapy
Volume:
5
Page:
181-194
Author(s):
Berma M. Kinsey, Charles L. Densmore and Frank M. Orson
Gene Therapy in In Vivo Isolated Perfusion Models
Journal:
Current Gene Therapy
Volume:
5
Page:
195-202
Author(s):
Boudewijn van Etten, Alexander M.M. Eggermont, Sandra T. van Tiel, G. Ambagtsheer, Johannes H.W. de Wilt and Timo L.M. ten Hagen
Adenovirus-mediated Transgene-engineered Dendritic Cell Vaccine of Cancer
Journal:
Current Gene Therapy
Volume:
5
Page:
237-247
Author(s):
Qiaohua Wu, Dajing Xia, Svein Carlsen and Jim Xiang
Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1105-1117
Author(s):
M. Folini and N. Zaffaroni
Novel Insights Into c-Src
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1119-1130
Author(s):
O. Alper and E. T. Bowden
Hsp90 Inhibitor Geldanamycin and Its Derivatives as Novel Cancer Chemotherapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1131-1138
Author(s):
Y. Miyata